The Cancer Letter

Inside information on cancer research and drug development

Vol.
32
No.
11
November 27, 2009Nov 27, 2009
Free
DOWNLOAD THE PDF

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer

Age Shouldn’t Determine Lung Cancer Treatment, ASCO Says In New Guideline

Patch-Lozenge Combination Best For Smoking Cessation

Lower Dose Dexamethasone Can Be Used To Treat Newly Diagnosed Myeloma

Low Total Cholesterol Linked To Higher Risk Of Cancer; Higher HDL Associated With Decreased Risk Of Cancer

Black-White Disparity Seen In End Of Life Treatment

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

The Clinical Cancer Letter To End Print Edition In 2010

NCI Cooperative Group Clinical Trials Approved

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.
COMPLETE OUR SURVEY

Login

Site license subscribers:
Log in with your IP | Register a sponsored account